Dapsone: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== Background == |
|||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
== Dosing == |
|||
* '''Dermatitis herpetiformis:''' Start at 50 mg PO daily, increase to 300 mg daily, or higher to achieve full control, reduce to minimum maintenance dosage as soon as possible |
|||
* '''PJP prophylaxis (primary or secondary):''' |
|||
** 100 mg PO once daily or in 2 divided doses as monotherapy |
|||
** Continue until CD4 count >200 cells/mm3 for >3 months |
|||
* '''PJP treatment:''' 100 mg PO once daily in combination with [[trimethoprim]] for 21 days |
|||
[[Category:Antibiotics]] |
[[Category:Antibiotics]] |
||
Revision as of 13:11, 3 March 2021
Background
- Diamino-diphenyl sulfone
Indications
- Second-line PJP prophylaxis (CD4 <200)
- Rifampicin and clofazimine as multidrug therapy (MDT) for the treatment of Mycobacterium leprae
Dosing
- Dermatitis herpetiformis: Start at 50 mg PO daily, increase to 300 mg daily, or higher to achieve full control, reduce to minimum maintenance dosage as soon as possible
- PJP prophylaxis (primary or secondary):
- 100 mg PO once daily or in 2 divided doses as monotherapy
- Continue until CD4 count >200 cells/mm3 for >3 months
- PJP treatment: 100 mg PO once daily in combination with trimethoprim for 21 days
